Basilea Pharmaceutical Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Implantable Cardiac Monitors Market: Global Opportunity and Industry Analysis Implantable Cardiac Monitors Market Expected to Reach $678.3 Million, Globally, by 2023 tusharJune 2, 2021 Global implantable cardiac monitors market was valued at $410.4 million in 2016, and is projected to reach $678.3 million by 2023, growing at a CAGR of 7.4% from 2017 to 2023. The cardiac arrhythmias indication accounted for nearly half of the market share in 2016. Implantable cardiac monitors assist physicians to assess a patients health with respect to his/her cardiac rhythm. These devices help in the treatment of cardiac patients ensuring that the patient has a well-functioning heart. They are used to monitor several serious cardiac disorders such as heart failure, atrial fibrillation, and indications of recent heart attack. A patient can constantly be monitored for almost two to three years with the help of implantable loop recorders or cardiac monitors, due to an increase in the use of advance

United statesKoninklijke philipsAgilent technologies incBasilea pharmaceutical ltdBoston scientific corporationNihon kohden corporationBiotronik se coJarvik heart incAldrich corporationAstellas pharma incPhoenix heart centerReliantheart incAbbott laboratoriesAbiomed incPurchase enquiryImplantable cardiac monitors market